To verify the effects of miR-301a-3p on trastuzumab resistance, we established stably transfected GC cells by over-expressing and suppressing (RNAi) the expression of miR-301a-3p, while HER2 level showed no significant change (Supplementary Fig. S2g–h). The gene discussed is ERBB2; the disease is gastric cancer.